Cite
MLA Citation
Michael Platten et al.. “ATIM-33. NOA-16: A FIRST-IN-MAN MULTICENTER PHASE I CLINICAL TRIAL OF THE GERMAN NEUROONCOLOGY WORKING GROUP EVALUATING A MUTATION-SPECIFIC PEPTIDE VACCINE TARGETING IDH1R132H IN PATIENTS WITH NEWLY DIAGNOSED MALIGNANT ASTROCYTOMAS.” Neuro-oncology, vol. 20, n.d., pp. vi8–vi9. http://access.bl.uk/ark:/81055/vdc_100095200036.0x000017